Stock Market & Financial Investment News

News Breaks December 14, 2012 09:05 EDT CYTX Cytori Therapeutics 7.02M share Spot Secondary priced at $2.85 Lazard Capital acted as sole book running manager for the offering. News For CYTX From The Last 14 Days Check below for free stories on CYTX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 9, 2013 16:07 EDT CYTX Cytori Therapeutics reports Q1 EPS (11c), consensus (15c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.